ARTELO BIOSCIENCES, INC. Unrealized Gain (Loss) on Investments
ARTELO BIOSCIENCES, INC. (ARTL) reported Unrealized Gain (Loss) on Investments of -$5.00 thousand for the 4-month period ending 2021-12-31, per its 10-KT filed 2022-03-21.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2022-03-21
- ARTELO BIOSCIENCES, INC. unrealized gain (loss) on investments for fiscal 2021 was $0.00.
- ARTELO BIOSCIENCES, INC. unrealized gain (loss) on investments for fiscal 2020 was $0.00.
| Period end | Unrealized Gain (Loss) on Investments 4 month | Unrealized Gain (Loss) on Investments 12 month |
|---|---|---|
| 2021-12-31 | -$5.00K 10-KT · filed 2022-03-21 | |
| 2021-08-31 | $0.00 10-KT · filed 2022-03-21 | |
| 2020-12-31 | $0.00 10-KT · filed 2022-03-21 | |
| 2020-08-31 | $0.00 10-KT · filed 2022-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |